Clinical Trial Update: Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group [Phase 2]

View source ↗

Summary

A multicenter Phase II randomized trial is evaluating radiochemotherapy with or without durvalumab in locally advanced anal cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Goethe University | Conditions: Anal Cancer, Anal Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING